**Robust IPO activity in 2026 has been fueled by strong equity demand for sizable offerings, particularly in AI and technology sectors, with U.S. deals through mid-September already raising over $146 billion according to Renaissance Capital data.** Corporate and SPAC issuances have delivered record proceeds in several quarters, aided by solid recent performance of new listings and resilient capital markets, though elevated Treasury yields near multi-year highs and seasonal factors have prompted selective postponements. Biotechs continue to access the market regularly, while high-profile candidates monitor timing around potential mega-deals such as Anthropic’s targeted listing before Thanksgiving. Multiple filings remain active into Q4, with pipelines including data-center and consumer names, setting the stage for further debuts before year-end amid ongoing monetary policy and rate sensitivity.